Lukas Hainz

In the ever-evolving landscape of cancer treatment, immunotherapies such as CAR T-cell therapy and T-cell engager therapies have emerged as revolutionary options, offering renewed hope to patients battling hematologic malignancies like lymphomas, leukemias, and multiple myeloma. However, these

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the world of Tissue Regenix Group, a key player in regenerative

Every year, hundreds of children are diagnosed with medulloblastoma, a highly aggressive brain tumor that ranks as one of the most common malignant brain cancers in pediatric patients, leaving families grappling with not only the fear of survival but also the long-term consequences of harsh

In a world where breast cancer remains one of the most prevalent and life-altering diseases affecting millions of women globally, a groundbreaking initiative is poised to transform how this illness is detected and managed through innovative technology. The BosomShield project, supported by the

Imagine a future where detecting cancer at its earliest stage is as straightforward as swallowing a pill and analyzing a urine sample in the privacy of one’s home, without the need for intimidating hospital visits or invasive procedures. This transformative vision is taking shape through a

The pharmaceutical industry stands at a critical juncture, where the urgent need for faster, more sustainable, and patient-focused solutions is driving unprecedented change, as vividly demonstrated at the DCAT Summit held on June 4–5 in Lugano, Switzerland. Under the compelling theme "Expedition

A startling revelation has emerged from Arizona’s Medicaid program, known as the Arizona Health Care Cost Containment System (AHCCCS), raising serious questions about oversight and accountability at the highest levels. The chief medical officer, a pivotal figure in shaping health policies for some

In a striking move that underscores the growing emphasis on domestic manufacturing in the biopharmaceutical sector, Amgen, a titan in the American biotech landscape, has committed a substantial $650 million to expand its biologics facility in Juncos, Puerto Rico. This investment is not merely a

In a striking revelation from 2023, researchers in Egypt uncovered a previously unknown mutation of feline parvovirus (FPV), named Thr390Ala, which rapidly emerged among local cat populations, capturing the attention of veterinary scientists worldwide. This discovery, stemming from an in-depth

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the industry. With a strong background in research and development, Ivan has been at the forefront of integrating cutting-edge technologies into healthcare. Today, we’re